Skip to content

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety

Telemedicine Control Tower for the Operating Room: Navigating Information, Care and Safety - Randomized Pragmatic Trial

Status
Completed
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03923699
Acronym
TECTONICS
Enrollment
79560
Registered
2019-04-23
Start date
2019-07-01
Completion date
2023-01-31
Last updated
2024-07-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perioperative/Postoperative Complications, Surgery, Surgery--Complications

Keywords

Telemedicine, Anesthesia Control Tower, Machine Learning, Forecasting Algorithms, Decision Support, Randomized Controlled Trial

Brief summary

Medical errors account for thousands of potentially preventable deaths each year. With the annual increase of surgical cases there is a need for research into the potential utility of a telemedicine-based control center for the operating room to assess risk, diagnose negative patient trajectories, implement evidence-based practices, and improve outcomes.

Detailed description

This will be a single center, randomized, controlled, phase 3 pragmatic clinical trial. Forty-eight operating rooms will be randomized daily to receive support from the ACT or not. All adults (eighteen years and older) undergoing surgical procedures in these operating rooms will be included and followed until 30-days after their surgery. Clinicians in operating rooms randomized to 'intervention' will receive decision support from clinicians in the ACT. In operating rooms not randomized to receive decision support from the ACT, the current standard of anesthesia care will be delivered. The intention-to-treat principle will be followed for all analyses.

Interventions

DEVICEAnesthesia Control Tower monitoring

Real time data will be monitored through the AlertWatch® system as well as the patient's EHR.

Sponsors

National Institute of Nursing Research (NINR)
CollaboratorNIH
Washington University School of Medicine
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
SINGLE (Subject)

Masking description

Anesthesia practitioner un-blinded to intervention, subject blinded to intervention, data analyst blinded to intervention, ACT Clinicians un-blinded to intervention

Intervention model description

Randomized Parallel assignment

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* All patients 18 years or older undergoing surgery at Barnes Jewish Hospital in St. Louis, MO

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Thirty-day Postoperative Mortality30 days post-opThis will include death of any cause occurring in or out of the hospital, within 30 days of the index surgery.
Number of Participants With Postoperative Delirium7 days post-opDefined as an acute change in consciousness or cognition. It has a fluctuating course, and is characterized by inattention, disorganized thinking and altered level of consciousness. The institution has trained the nursing staff on our surgical intensive care units to assess all patients for postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) instrument.
Number of Participants With Postoperative Respiratory Failure30 days post-opDefined as mechanical ventilation for greater than 24 hours after surgery, or unplanned postoperative re-intubation and mechanical ventilation within 30 days of surgery.
Number of Participants With Postoperative Acute Kidney Injury7 days post-opDiagnosed when any of the following three criteria are met: (i) an increase in serum creatinine by 50% compared with preoperative within 7 days, (ii) any increase in serum creatinine \> 0.3 mg/dL in 48 hours, or (iii) oliguria (urine output \<0.5 mL/kg/hr for 6-12 hours).

Secondary

MeasureTime frameDescription
Blood Glucose Management1 dayPercentage of patients with blood glucose ≥ 200 mg/dL at end of surgery.
Temperature Management1 dayPercentage of patients with Temperature ≥ 36°C at end of surgery.
Fresh Gas Flow Rates1 dayPercentage of patients with efficient fresh gas flow for ≥90% of the anesthetic maintenance period.
Measured Anesthetic Concentration1 dayPercentage of patients without ≥ 15 consecutive min of anesthetic concentration ≤ 0.3 MAC during anesthetic maintenance period.
Antibiotic Redosing1 dayPercentage of patients with antibiotic redosing compliant with guidelines developed by the institutional pharmacy and therapeutics committee.
Mean Arterial Pressure Management1 dayPercentage time during surgery with mean arterial pressure ≥ 60 mmHg
Mean Airway Pressure With Mechanical Ventilation1 dayPercentage time during surgery with low PIP (peak inspiratory pressure)

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard of Care Arm
Operating rooms in the standard of care group will be monitored but, the ACT clinicians will not contact the operating room unless it is clinically necessary for patient safety purposes.
39,750
Anesthesia Control Tower Monitoring
Clinicians in the Anesthesiology Control Tower will provide extra support for the anesthesiology team in the operating room using AlertWatch and integrating machine-learning forecasting algorithms for adverse outcomes. Anesthesia Control Tower monitoring: Real time data will be monitored through the AlertWatch® system as well as the patient's EHR.
39,810
Total79,560

Baseline characteristics

CharacteristicStandard of Care ArmTotalAnesthesia Control Tower Monitoring
Age, Continuous57.2 years
STANDARD_DEVIATION 17
57.2 years
STANDARD_DEVIATION 16.9
57.2 years
STANDARD_DEVIATION 16.8
ASA Physical Status
ASA 1
1406 Participants2819 Participants1413 Participants
ASA Physical Status
ASA 2
12071 Participants24188 Participants12117 Participants
ASA Physical Status
ASA 3
17295 Participants34577 Participants17282 Participants
ASA Physical Status
ASA 4
4009 Participants8043 Participants4034 Participants
ASA Physical Status
ASA 5
132 Participants252 Participants120 Participants
ASA Physical Status
Unknown or Other
4837 Participants9681 Participants4844 Participants
Race (NIH/OMB)
American Indian or Alaska Native
112 Participants223 Participants111 Participants
Race (NIH/OMB)
Asian
417 Participants870 Participants453 Participants
Race (NIH/OMB)
Black or African American
7776 Participants15651 Participants7875 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
58 Participants121 Participants63 Participants
Race (NIH/OMB)
Unknown or Not Reported
3792 Participants7472 Participants3680 Participants
Race (NIH/OMB)
White
27595 Participants55223 Participants27628 Participants
Region of Enrollment
United States
39750 participants79560 participants39810 participants
Sex/Gender, Customized
Female
19752 Participants39565 Participants19813 Participants
Sex/Gender, Customized
Male
19994 Participants39986 Participants19992 Participants
Sex/Gender, Customized
Unknown or Other
4 Participants9 Participants5 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
899 / 39,750866 / 39,810
other
Total, other adverse events
0 / 39,7500 / 39,810
serious
Total, serious adverse events
0 / 39,7500 / 39,810

Outcome results

Primary

Number of Participants With Postoperative Acute Kidney Injury

Diagnosed when any of the following three criteria are met: (i) an increase in serum creatinine by 50% compared with preoperative within 7 days, (ii) any increase in serum creatinine \> 0.3 mg/dL in 48 hours, or (iii) oliguria (urine output \<0.5 mL/kg/hr for 6-12 hours).

Time frame: 7 days post-op

Population: Patients with diagnosed renal failure, serum creatinine \>4 mg/dl, and dialysis in the last week are excluded.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmNumber of Participants With Postoperative Acute Kidney Injury2784 Participants
Anesthesia Control Tower MonitoringNumber of Participants With Postoperative Acute Kidney Injury2736 Participants
p-value: 0.4295% CI: [0.92, 1.05]Regression, Poisson
Primary

Number of Participants With Postoperative Delirium

Defined as an acute change in consciousness or cognition. It has a fluctuating course, and is characterized by inattention, disorganized thinking and altered level of consciousness. The institution has trained the nursing staff on our surgical intensive care units to assess all patients for postoperative delirium using the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU) instrument.

Time frame: 7 days post-op

Population: Patients that did not have a CAM-ICU performed, or CAM-ICU scores within 30 minutes of a documented deep level of sedation (Richmond Agitation Sedation Scale \< -3) are excluded. All other delirium assessments within 7 days will be included, with any positive evaluations yielding a positive event.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmNumber of Participants With Postoperative Delirium1506 Participants
Anesthesia Control Tower MonitoringNumber of Participants With Postoperative Delirium1502 Participants
p-value: 0.9295% CI: [0.92, 1.1]Regression, Poisson
Primary

Number of Participants With Postoperative Respiratory Failure

Defined as mechanical ventilation for greater than 24 hours after surgery, or unplanned postoperative re-intubation and mechanical ventilation within 30 days of surgery.

Time frame: 30 days post-op

Population: Patients with tracheostomies and preoperative ventilation are excluded. Airway events within 24 hours after surgeries within 30 days of the index operation are excluded. That is, a 24 hour window of ventilation is allowed after all surgeries without triggering a positive event.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmNumber of Participants With Postoperative Respiratory Failure1301 Participants
Anesthesia Control Tower MonitoringNumber of Participants With Postoperative Respiratory Failure1282 Participants
p-value: 0.6895% CI: [0.89, 1.09]Regression, Poisson
Primary

Thirty-day Postoperative Mortality

This will include death of any cause occurring in or out of the hospital, within 30 days of the index surgery.

Time frame: 30 days post-op

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmThirty-day Postoperative Mortality899 Participants
Anesthesia Control Tower MonitoringThirty-day Postoperative Mortality866 Participants
p-value: 0.4195% CI: [0.85, 1.08]Regression, Poisson
Secondary

Antibiotic Redosing

Percentage of patients with antibiotic redosing compliant with guidelines developed by the institutional pharmacy and therapeutics committee.

Time frame: 1 day

Population: Patients without an indicated redosing event are excluded.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmAntibiotic Redosing5520 Participants
Anesthesia Control Tower MonitoringAntibiotic Redosing5629 Participants
p-value: 0.9595% CI: [0.95, 1.05]Regression, Poisson
Secondary

Blood Glucose Management

Percentage of patients with blood glucose ≥ 200 mg/dL at end of surgery.

Time frame: 1 day

Population: Patients with missing secondary outcomes are not included in the analysis of those outcomes.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmBlood Glucose Management1786 Participants
Anesthesia Control Tower MonitoringBlood Glucose Management1848 Participants
p-value: 0.395% CI: [0.95, 1.13]Regression, Poisson
Secondary

Fresh Gas Flow Rates

Percentage of patients with efficient fresh gas flow for ≥90% of the anesthetic maintenance period.

Time frame: 1 day

Population: Only times with \> 0.3 age adjusted MAC are included. Patients with missing secondary outcomes are not included in the analysis of those outcomes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmFresh Gas Flow Rates19899 Participants
Anesthesia Control Tower MonitoringFresh Gas Flow Rates19839 Participants
p-value: 0.5195% CI: [0.97, 1.02]Regression, poisson
Secondary

Mean Airway Pressure With Mechanical Ventilation

Percentage time during surgery with low PIP (peak inspiratory pressure)

Time frame: 1 day

Population: Patients with missing secondary outcomes are not included in the analysis of those outcomes.

ArmMeasureValue (MEAN)Dispersion
Standard of Care ArmMean Airway Pressure With Mechanical Ventilation0.92 percentage of timeStandard Deviation 0.21
Anesthesia Control Tower MonitoringMean Airway Pressure With Mechanical Ventilation0.92 percentage of timeStandard Deviation 0.22
p-value: 0.3795% CI: [-0.01, 0]Regression, Linear
Secondary

Mean Arterial Pressure Management

Percentage time during surgery with mean arterial pressure ≥ 60 mmHg

Time frame: 1 day

Population: Patients with missing secondary outcomes are not included in the analysis of those outcomes.

ArmMeasureValue (MEAN)Dispersion
Standard of Care ArmMean Arterial Pressure Management0.96 percentage of timeStandard Deviation 0.08
Anesthesia Control Tower MonitoringMean Arterial Pressure Management0.96 percentage of timeStandard Deviation 0.08
p-value: 0.2995% CI: [0, 0]Regression, Linear
Secondary

Measured Anesthetic Concentration

Percentage of patients without ≥ 15 consecutive min of anesthetic concentration ≤ 0.3 MAC during anesthetic maintenance period.

Time frame: 1 day

Population: Patients with doses of sedatives at greater than the following dose-rates are excluded: Propofol \> 40 mcg/kg/min, Ketamine \> 0.3 mg/kg/hr. Patients with missing secondary outcomes are not included in the analysis of those outcomes

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmMeasured Anesthetic Concentration29851 Participants
Anesthesia Control Tower MonitoringMeasured Anesthetic Concentration30087 Participants
p-value: 0.8595% CI: [0.98, 1.02]Regression, Poisson
Secondary

Temperature Management

Percentage of patients with Temperature ≥ 36°C at end of surgery.

Time frame: 1 day

Population: Patients with missing secondary outcomes are not included in the analysis of those outcomes.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Standard of Care ArmTemperature Management27101 Participants
Anesthesia Control Tower MonitoringTemperature Management27398 Participants
p-value: 0.9995% CI: [0.98, 1.02]Regression, Poisson

Source: ClinicalTrials.gov · Data processed: Mar 1, 2026